Harrow (HROW) Amortization of Deferred Charges (2017 - 2026)

Harrow's (HROW) quarterly Amortization of Deferred Charges came in at $451000.0 in Q1 2026, down 64.63% year-on-year from $1.3 million in Q1 2025, and up 25.98% quarter-over-quarter from $358000.0 in Q4 2025.

Harrow (HROW) Amortization of Deferred Charges (2017 - 2026) Analysis & Trends

Harrow's Amortization of Deferred Charges history runs 10 years deep, the most recent figure standing at $451000.0 for Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges fell 64.63% year-over-year to $451000.0 in Q1 2026; TTM through Mar 2026 was $1.1 million, a 59.97% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, down 3.69% from the prior year.
  • Amortization of Deferred Charges rose to $451000.0 in Q1 2026 per HROW's latest filing, from $358000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $3.6 million in Q4 2023 and bottomed at $124000.0 in Q1 2022.
  • The 5-year median for Amortization of Deferred Charges is $197000.0 (2022), against an average of $631529.4.
  • Across the five-year window, Amortization of Deferred Charges soared 1705.08% in 2023 and slumped 70.66% in 2025, its largest moves.
  • Year by year, Amortization of Deferred Charges stood at $197000.0 in 2022, then surged by 1705.08% to $3.6 million in 2023, then plunged by 65.69% to $1.2 million in 2024, then slumped by 70.66% to $358000.0 in 2025, then gained by 25.98% to $451000.0 in 2026.
  • Per Business Quant, the three latest HROW Amortization of Deferred Charges figures stand at $451000.0 (Q1 2026), $358000.0 (Q4 2025), and $145000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.42 Bn 87.55 Bn -
2 Teva Pharmaceutical Industries 35.86 Bn 32.12 Bn 1.97 Bn
3 Zoetis 32.46 Bn 30.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.52 Bn 23.46 Bn 4.39 Bn
5 United Therapeutics 23.15 Bn 20.99 Bn 648.10 Mn
6 RedHill Biopharma 21.17 Bn 21.17 Bn -
7 Viatris 20.32 Bn 18.51 Bn 1.16 Bn
8 Neurocrine Biosciences 17.74 Bn 16.42 Bn 800.70 Mn
9 Elanco Animal Health 12.63 Bn 12.20 Bn 785.00 Mn
10 Harrow 1.42 Bn 1.32 Bn 27.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 451,000.00
Mar 31, 2026 451,000.00
Dec 31, 2025 358,000.00
Dec 31, 2025 358,000.00
Sep 30, 2025 145,000.00
Sep 30, 2025 145,000.00
Jun 30, 2025 195,000.00
Jun 30, 2025 195,000.00
Mar 31, 2025 1.28 Mn
Mar 31, 2025 1.28 Mn
Dec 31, 2024 1.22 Mn
Dec 31, 2024 1.22 Mn
Sep 30, 2024 197,000.00
Sep 30, 2024 197,000.00
Jun 30, 2024 178,000.00
Jun 30, 2024 178,000.00
Mar 31, 2024 976,000.00
Mar 31, 2024 976,000.00
Dec 31, 2023 3.56 Mn
Dec 31, 2023 3.56 Mn